Physician profile
David E Dine
NPI 1396289534
$864.49
in general payments reported to CMS, 2019-2025
13 companies · $8.67 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $727 · 2022: $83.97 · 2023: $23.22 · 2024: $21.85 · 2025: $8.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $53.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $53.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $373.71 | 2021-2022 | |
| Myovant Sciences INC. | $143.15 | 2021 | |
| Axonics, INC. | $87.01 | 2021-2024 | Axonics |
| Clarus Therapeutics INC. | $61.39 | 2021 | |
| Antares Pharma, INC. | $52.51 | 2021 | |
| Blue Earth Diagnostics | $25.13 | 2021 | |
| Teleflex LLC | $24.95 | 2021 | |
| Janssen Biotech, INC. | $22.73 | 2021 | |
| Dentsply Ih INC. | $21.06 | 2021 | |
| Abbvie INC. | $18.96 | 2021 | |
| Acerus Pharmaceuticals Corporation | $12.97 | 2021 | |
| Endo Pharmaceuticals INC. | $12.25 | 2021 | |
| Boston Scientific Corporation | $8.67 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.